Total Current Liabilities

$46.74M

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$37.45Mperiod endingDec 31, 2025

LGND FY Current Liabilities ($8.10M → $37.45M)

Annual total current liabilities

High-resolution chart · PNG

LGND total current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Total Current Liabilities — Annual fiscal periods (USD)
Period ending	Total Current Liabilities (USD)
Dec 31, 2025	37,447,000
Dec 31, 2024	37,112,000
Dec 31, 2023	16,782,000
Dec 31, 2022	98,810,000
Dec 31, 2021	41,665,000
Dec 31, 2020	100,111,000
Dec 31, 2019	17,002,000
Dec 31, 2018	82,249,000
Dec 31, 2017	238,868,000
Dec 31, 2016	227,129,000
Dec 31, 2015	20,836,000
Dec 31, 2014	22,779,000
Dec 31, 2013	28,939,000
Dec 31, 2012	35,439,000
Dec 31, 2011	43,643,000
Dec 31, 2010	35,630,000
Dec 31, 2009	52,172,000
Dec 31, 2008	70,614,000
Dec 31, 2007	50,968,000
Dec 31, 2006	170,810,000
Dec 31, 2005	235,211,000
Dec 31, 2004	216,712,000
Dec 31, 2003	54,049,000
Dec 31, 2002	30,535,000
Dec 31, 2001	31,726,000
Dec 31, 2000	28,415,000
Dec 31, 1999	20,700,000
Dec 31, 1998	26,900,000
Dec 31, 1997	21,700,000
Dec 31, 1996	13,800,000
Dec 31, 1995	15,700,000
Dec 31, 1994	8,100,000